About Kaiser Permanente Medical Center Lab Drawing Station
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Kaiser Permanente Medical Center Lab Drawing Station
During the past decade, Kaiser Permanente Medical Center Lab Drawing Station conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Adjuvant Hormone Therapy in Treating Women With Operable Breast Cancer
1987-09-01
Unknown status
Radiation Therapy With and Without Combination Chemotherapy in Patients With Resected Anaplastic Oligodendroglioma
1996-08-01
Completed
350
Radiation Therapy Compared With Chemotherapy in Treating Patients With Stage I Testicular Cancer
1998-04-01
2005-07-01
Completed
800
Fluorouracil in Treating Patients With Recurrent or Metastatic Bladder Cancer
1997-12-01
2009-03-01
Completed
45
Combination Chemotherapy With or Without Rituximab in Treating Patients With Relapsed Non-Hodgkin's Lymphoma
1999-05-01
2017-07-19
Completed
475
Chemotherapy in Treating Patients With Newly Diagnosed Chronic Lymphocytic Leukemia
1999-10-01
2007-07-01
Completed
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Kaiser Permanente Medical Center Lab Drawing Station"
#1 collaborator was "Astellas Pharma Inc" with 1 trials as a collaborator, "Medivation LLC, a wholly owned subsidiary of Pfizer Inc." with 1 trials as a collaborator and "Medivation, Inc." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were
collaborators in the rest 3 trials.
Clinical Trials Conditions at Kaiser Permanente Medical Center Lab Drawing Station
According to Clinical.Site data, the most researched conditions in "Kaiser Permanente Medical Center Lab Drawing Station" are
"BRCA 1 Gene Mutation" (1 trials), "BRCA 2 Gene Mutation" (1 trials), "Breast Neoplasms" (1 trials) and "Prostate Cancer" (1 trials). Many other conditions were trialed in "Kaiser Permanente Medical Center Lab Drawing Station" in a lesser frequency.
Clinical Trials Intervention Types at Kaiser Permanente Medical Center Lab Drawing Station
Most popular intervention types in "Kaiser Permanente Medical Center Lab Drawing Station" are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "Bicalutamide" (1 trials), "Enzalutamide" (1 trials), "Physician's-Choice" (1 trials) and "talazoparib" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Kaiser Permanente Medical Center Lab Drawing Station
The vast majority of trials in "Kaiser Permanente Medical Center Lab Drawing Station" are
1 trials for "All" genders and 1 trials for "Male" genders.
Clinical Trials Status at Kaiser Permanente Medical Center Lab Drawing Station
Currently, there are NaN active trials in "Kaiser Permanente Medical Center Lab Drawing Station".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Kaiser Permanente Medical Center Lab Drawing Station,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Kaiser Permanente Medical Center Lab Drawing Station, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".